Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study ; volume:30 ; number:4 ; day:8 ; month:2 ; year:2023 ; pages:1642-1652 ; date:8.2023
Journal of nuclear cardiology ; 30, Heft 4 (8.2.2023), 1642-1652, 8.2023
- Urheber
-
Boczar, Kevin E.
Beanlands, Rob S.
Glassman, Steven J.
Wang, Jerry
Zeng, Wanzhen
deKemp, Robert A.
Ward, Natalie C.
Fehlmann, Christophe A.
Wells, George A.
Karsh, Jacob
Dwivedi, Girish
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12350-023-03204-8
- URN
-
urn:nbn:de:101:1-2023102710131297808889
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boczar, Kevin E.
- Beanlands, Rob S.
- Glassman, Steven J.
- Wang, Jerry
- Zeng, Wanzhen
- deKemp, Robert A.
- Ward, Natalie C.
- Fehlmann, Christophe A.
- Wells, George A.
- Karsh, Jacob
- Dwivedi, Girish
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review
[18F]FDG PET/MRI in rectal cancer
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review
[18F]FDG PET/MRI in rectal cancer
Nicht-FDG-PET
Economic impact of biologic utilization patterns in patients with psoriatic arthritis
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
FDG-PET in lymphoma
FDG-PET AND PET/CT-Part I
Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
FDG-PET/CT in lymphoma
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
FDG PET/CT depicts cutaneous plasmocytoma
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review